132 related articles for article (PubMed ID: 20833691)
1. Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.
Luan Y; Guo Y; Li S; Yu B; Zhu S; Li S; Li N; Tian Z; Peng C; Cheng J; Li Q; Cui J; Tian Y
Europace; 2010 Dec; 12(12):1713-8. PubMed ID: 20833691
[TBL] [Abstract][Full Text] [Related]
2. Source of inflammatory markers in patients with atrial fibrillation.
Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
[TBL] [Abstract][Full Text] [Related]
3. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
[TBL] [Abstract][Full Text] [Related]
5. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
[TBL] [Abstract][Full Text] [Related]
8. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery?
Ziabakhsh-Tabari S
Saudi Med J; 2008 Oct; 29(10):1429-31. PubMed ID: 18946567
[TBL] [Abstract][Full Text] [Related]
9. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting.
Ishida K; Kimura F; Imamaki M; Ishida A; Shimura H; Kohno H; Sakurai M; Miyazaki M
Eur J Cardiothorac Surg; 2006 Apr; 29(4):501-5. PubMed ID: 16439145
[TBL] [Abstract][Full Text] [Related]
10. Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines.
Cheng T; Wang XF; Hou YT; Zhang L
Mol Med Rep; 2012 Sep; 6(3):581-4. PubMed ID: 22684635
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers according to types of atrial fibrillation.
Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in atrial fibrillation.
Guo Y; Lip GY; Apostolakis S
J Am Coll Cardiol; 2012 Dec; 60(22):2263-70. PubMed ID: 23194937
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
14. Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly.
Berge T; Ulimoen SR; Enger S; Arnesen H; Seljeflot I; Tveit A
Scand J Clin Lab Invest; 2013; 73(4):326-33. PubMed ID: 23586783
[TBL] [Abstract][Full Text] [Related]
15. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in the genesis and perpetuation of atrial fibrillation.
Engelmann MD; Svendsen JH
Eur Heart J; 2005 Oct; 26(20):2083-92. PubMed ID: 15975993
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
Am Heart J; 2004 Sep; 148(3):462-6. PubMed ID: 15389233
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome.
Yamaoka-Tojo M; Tojo T; Masuda T; Machida Y; Kitano Y; Kurosawa T; Izumi T
Heart Vessels; 2003 Sep; 18(4):183-7. PubMed ID: 14520485
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study.
Maida CD; Vasto S; Di Raimondo D; Casuccio A; Vassallo V; Daidone M; Del Cuore A; Pacinella G; Cirrincione A; Simonetta I; Della Corte V; Rizzica S; Geraci G; Tuttolomondo A; Pinto A
Aging (Albany NY); 2020 May; 12(9):8423-8433. PubMed ID: 32364529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
